Pharmaco - Press Releases

Date	Title	Company
11-Dec-2019	FDA issues warning letter for not including the most serious risks in advertisement for medication-assisted treatment drug	U.S. Food and Drug Administration
11-Dec-2019	Why Pharmaceutical R&D Global Spending Could Exceed $200 Billion by 2024	Financialnewsmedia.com
11-Dec-2019	Leucadia Pharmaceuticals Launches Sodium Tetradecyl Sulfate Injection	Leucadia Pharmaceuticals
11-Dec-2019	Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma	Kazia Therapeutics Ltd
11-Dec-2019	Inceptua Appoints New CEO	Inceptua
11-Dec-2019	Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value	Correvio Pharma Corp
11-Dec-2019	MagForce AG: 'NanoTherm School' successfully enters its second round with Module B	MagForce AG
11-Dec-2019	UKI2S, Catapult Ventures and Jonathan Milner invest £500K in gene modulation newcomer Pencil Biosciences	Sciad Newswire
11-Dec-2019	UKI2S, Catapult Ventures and Jonathan Milner invest £500K in gene modulation newcomer Pencil Biosciences	Sciad Newswire
11-Dec-2019	Biotest AG: Biotest AG opens fourth plasma collection centre in Czech Republic	Biotest AG
10-Dec-2019	Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion	Sanofi
10-Dec-2019	Vaccine Regimen from Janssen and Bavarian Nordic to Support Republic of Rwanda’s Preparedness Against Ebola Outbreak	Bavarian Nordic
10-Dec-2019	Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis	Galderma
10-Dec-2019	Abeona Therapeutics Cleared to Initiate Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa	Abeona Therapeutics Inc
10-Dec-2019	Acalabrutinib (Calquence) significantly prolonged the time patients lived without disease progression or death in previously untreated chronic lymphocytic leukaemia	AstraZeneca
10-Dec-2019	Upperton is Launching an Enabling Technology Screening Protocol	Upperton Pharma Solutions
10-Dec-2019	Precipice Design Reimagines NIOX VERO® Asthma Detection and Management System	Precipice Design
10-Dec-2019	bluebird bio and Bristol-Myers Squibb Present Updated Data from Ongoing Phase 1 Study of BCMA-Targeted CAR T Cell Therapy bb21217 in Relapsed/Refractory Multiple Myeloma at 61st ASH Annual Meeting and Exposition	Bristol-Myers Squibb
10-Dec-2019	Vetter's Occupational Health Management Excels Again in Employee Wellness Initiatives	B3C newswire
10-Dec-2019	Vetter's Occupational Health Management Excels Again in Employee Wellness Initiatives	B3C newswire